Guizhou Salvage Pharmaceutical Co.,Ltd. (600227.SS)
CNY 2.74
(-1.43%)
CNY 2.74
(-1.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.24 Billion | 2.51 Billion | 2.18 Billion | 1.92 Billion | 2.02 Billion | 2.43 Billion |
| Cost of Revenue | 2.06 Billion | 2.37 Billion | 1.75 Billion | 1.32 Billion | 1.53 Billion | 1.58 Billion |
| Gross Profit | 177.29 Million | 145.56 Million | 421.67 Million | 604.43 Million | 487.27 Million | 846.04 Million |
| Operating Expenses | 327.47 Million | 302.56 Million | 351.97 Million | 383.68 Million | 419.11 Million | 459.9 Million |
| Selling, General and Administrative Expenses | 168.23 Million | 119.46 Million | 121.17 Million | 170.32 Million | 221.63 Million | 277.93 Million |
| Research and Development Expenses | 99.67 Million | 96.69 Million | 95.62 Million | 72.43 Million | 73.47 Million | 56.4 Million |
| Other Expenses | -13.62 Million | 86.4 Million | 135.17 Million | 140.92 Million | 123.99 Million | -30.55 Million |
| Cost and Expenses | 2.37 Billion | 2.67 Billion | 2.11 Billion | 1.7 Billion | 1.95 Billion | 2.04 Billion |
| Operating Income | -132.41 Million | -172.86 Million | 56.75 Million | 200.18 Million | 60.31 Million | 266.13 Million |
| Interest Expense | 44.44 Million | 20.03 Million | 19.56 Million | 31 Million | 44.47 Million | 71.72 Million |
| Income Tax Expense | -21.95 Million | 4.6 Million | -13.56 Million | 6.67 Million | 5.11 Million | 39.05 Million |
| Earnings before Tax | -145.93 Million | -366.87 Million | -70.2 Million | 59.04 Million | -1.7 Billion | 235.58 Million |
| Net Income | -119.27 Million | -371.48 Million | -56.64 Million | 55.6 Million | -1.71 Billion | 197.32 Million |
| Earnings Per Share Basic | -0.07 | -0.22 | -0.03 | 0.03 | -1.01 | 0.12 |
| Earnings Per Share Diluted | -0.07 | -0.22 | -0.03 | 0.03 | -1.01 | 0.11 |
| Weighted Average Shares Outstanding | 1.69 Billion | 1.69 Billion | 1.69 Billion | 1.69 Billion | 1.69 Billion | 1.69 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.69 Billion | 1.69 Billion | 1.69 Billion | 1.69 Billion | 1.69 Billion | 1.72 Billion |
| Gross Margin | 0.08 | 0.06 | 0.19 | 0.31 | 0.24 | 0.35 |
| EBIT Margin | 0.04 | 0.00 | 0.11 | 0.19 | 0.16 | 0.27 |
| Profit Margin | -0.05 | -0.15 | -0.03 | 0.03 | -0.84 | 0.08 |
| EBITDA | 97.91 Million | -156.36 Million | 127.93 Million | 267.04 Million | -1.38 Billion | 585.2 Million |
| Earnings Before Tax Margin | -0.06 | -0.07 | 0.03 | 0.10 | 0.03 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 637.48 Million | 629.71 Million | 437.34 Million | 2.24 Billion | 575.98 Million | 583.45 Million |
| Cost of Revenue | 555.4 Million | 558.47 Million | 397.83 Million | 2.06 Billion | 510.39 Million | 554.43 Million |
| Gross Profit | 82.07 Million | 71.23 Million | 39.5 Million | 177.29 Million | 65.59 Million | 29.02 Million |
| Operating Expenses | 62.16 Million | 39.92 Million | 62.17 Million | 327.47 Million | 84.79 Million | 83.44 Million |
| Selling, General and Administrative Expenses | 89.73 Million | -17.64 Million | 41.76 Million | - | 11.69 Million | 106.33 Million |
| Research and Development Expenses | 29.28 Million | 15.74 Million | 17.68 Million | - | 26.82 Million | 31.56 Million |
| Other Expenses | -56.84 Million | -852.87 Thousand | -538.8 Thousand | -13.51 Million | -3.52 Million | -18.17 Million |
| Cost and Expenses | 617.57 Million | 598.4 Million | 460.01 Million | 2.39 Billion | 595.18 Million | 637.87 Million |
| Operating Income | 3.46 Million | 4.05 Million | -38.96 Million | -132.41 Million | 123.55 Million | -86.96 Million |
| Interest Expense | 12.41 Million | 15.62 Million | 13.45 Million | 39.2 Million | 13.35 Million | 12.76 Million |
| Income Tax Expense | -232.15 Thousand | -236.49 Thousand | 675.29 Thousand | -21.95 Million | -5.97 Million | -2.9 Million |
| Earnings before Tax | 1.89 Million | 3.2 Million | -39.5 Million | -145.93 Million | 120.03 Million | -91.04 Million |
| Net Income | 2.12 Million | 3.43 Million | -40.18 Million | -119.27 Million | 126.67 Million | -87.24 Million |
| Earnings Per Share Basic | 0.00 | 0.00 | -0.02 | - | 0.02 | -0.05 |
| Earnings Per Share Diluted | 0.00 | 0.00 | -0.02 | - | 0.02 | -0.05 |
| Weighted Average Shares Outstanding | 1.68 Billion | 1.68 Billion | 1.69 Billion | 1.69 Billion | 1.69 Billion | 1.69 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.68 Billion | 1.68 Billion | 1.69 Billion | 1.69 Billion | 1.69 Billion | 1.69 Billion |
| Gross Margin | 0.13 | 0.11 | 0.09 | 0.08 | 0.11 | 0.05 |
| EBIT Margin | 0.02 | 0.05 | -0.06 | - | 0.31 | -0.10 |
| Profit Margin | 0.00 | 0.01 | -0.09 | -0.05 | 0.22 | -0.15 |
| EBITDA | 14.31 Million | 28.74 Million | -24.41 Million | - | 179.9 Million | -60.93 Million |
| Earnings Before Tax Margin | 0.01 | 0.01 | -0.09 | -0.06 | 0.21 | -0.15 |
5186
GWW
FEDFINA
AOT
OPTI
PRS